Cleaning Validation for Residual Estimation of Mometasone Furoate on Stainless-Steel Surface of Pharmaceutical Manufacturing Equipment Using a UHPLC-UV Method

References

1. 1.↵
   1. Pawar H. A.,
   2. Banerjee N. D.,
   3. Pawar S.,
   4. Pawar P.

   Current Perspectives on Cleaning Validation in Pharmaceutical Industry: A Scientific and Risk Based Approach. Int. J. Pharm. Phytopharm. Res. 2011, 1 (1), 8–16.

   OpenUrlGoogle Scholar
2. 2.↵
   Federal Government of Brazil. Agência Nacional de Vigilância Sanitária. ANVISA. Resolução RDC n. 17, 16 de Abril de 2010. Brasília: Diário Oficial da União 2010.

   Google Scholar
3. 3.↵
   Government of Canada. Guidance Document: Cleaning Validation Guidelines. Health Products and Food Branch Guide-0028, Minister of Public Works and Government Services: Ottawa, Ontario, 2007.

   Google Scholar
4. 4.↵
   International Conference for Harmonisation. Quality Guideline Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. ICH: Geneva, 2000.

   Google Scholar
5. 5.↵
   1. Porto L. V. F. M.,
   2. Fukumori N. T. O.,
   3. Matsuda M. M. N.

   Determination of Worst Case for Cleaning Validation of Equipment Used in the Radiopharmaceutical Production of Lyophilized Reagents for ^99mTc Labeling. Braz. J. Pharm. Sci. 2016, 52 (1), 105–112.

   OpenUrlGoogle Scholar
6. 6.↵
   U.S. Food and Drug Administration. Guidance for Industry Q7A: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services: Rockville, MD, 2001.

   Google Scholar
7. 7.↵
   1. Dong M. W.,
   2. Zhang K.

   Ultra-High-Pressure Liquid Chromatography (UHPLC) in Method Development. TrAC, Trends Anal. Chem. 2014, 63, 21–30.

   OpenUrlGoogle Scholar
8. 8.↵
   1. Walter T. H.,
   2. Andrews R. W.

   Recent Innovations in UHPLC Columns and Instrumentation. TrAC, Trends Anal. Chem. 2014, 63, 14–20.

   OpenUrlGoogle Scholar
9. 9.↵
   1. Gumustas M.,
   2. Kurbanoglu S.,
   3. Uslu B.,
   4. Ozkan S. A.

   UPLC versus HPLC on Drug Analysis: advantageous, Applications and Their Validation Parameters. Chromatographia 2013, 76 (21–22), 1365–1427.

   OpenUrlCrossRefWeb of ScienceGoogle Scholar
10. 10.↵
    1. D'Urzo A.

    Mometasone Furoate Dry-Powder Inhaler for the Control of Persistent Asthma. Expert Opin. Pharmacother. 2007, 8 (16), 2871–2884.

    OpenUrlPubMedGoogle Scholar
11. 11.↵
    1. Onrust S. V.,
    2. Lamb H. M.

    Mometasone Furoate: A Review of Its Intranasal Use in Allergic Rhinitis. Drugs 1998, 56 (4), 725–745.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
12. 12.↵
    1. Zitt M.,
    2. Kosoglou T.,
    3. Hubbell J.

    Mometasone Furoate Nasal Spray: A Review of Safety and Systemic Effects. Drug Saf. 2007, 30 (4), 317–326.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
13. 13.↵
    British Pharmacopoeia Commission. British Pharmacopoeia, Volume II, Monographs: Medicinal and Pharmaceutical Substances, Mometasone furoate. BPC: London, 2018.

    Google Scholar
14. 14.↵
    1. Sayed R. A.,
    2. El-Masri M. M.,
    3. Hassan W. S.,
    4. El-Mammli M. Y.,
    5. Shalaby A.

    Validated Stability-Indicating Methods for Determination of Mometasone Furoate in Presence of Its Alkaline Degradation Product. J. Chromatogr. Sci. 2018, 56 (3), 254–261.

    OpenUrlGoogle Scholar
15. 15.↵
    U.S. Pharmacopeial Convention. In USP 41–NF 36, Volume 2, Mometasone furoate monograph. USP: Rockville, MD, 2018.

    Google Scholar
16. 16.↵
    1. El-Bagary R. I.,
    2. Fouad M. A.,
    3. El-Shal M. A.,
    4. Tolba E. H.

    Forced Degradation of Mometasone Furoate and Development of Two RP-HPLC Methods for Its Determination with Formoterol Fumarate or Salicylic Acid. Arabian J. Chem. 2016, 9 (3), 493–505.

    OpenUrlGoogle Scholar
17. 17.↵
    1. Merey H. A.,
    2. El-Mosallamy S. S.,
    3. Hassan N. Y.,
    4. El-Zeany B. A.

    Validated Chromatographic Methods for the Simultaneous Determination of Mometasone Furoate and Formoterol Fumarate Dihydrate in a Combined Dosage Form. Bull. Fac. Pharm. (Cairo Univ.) 2016, 54 (1), 99–106.

    OpenUrlGoogle Scholar
18. 18.↵
    1. Youssef R. M.,
    2. Korany M. A.,
    3. Afify M. A.

    Development of a Stability Indicating HPLC-DAD Method for the Simultaneous Determination of Mometasone Furoate and Salicylic Acid in an Ointment Matrix. Anal. Methods 2014, 6 (10), 3410–3419.

    OpenUrlGoogle Scholar
19. 19.↵
    1. Ourique A. F.,
    2. Contri R. V.,
    3. Guterres S. S.,
    4. Beck R. C. R.,
    5. Pohlmann A. R.,
    6. Melero A.,
    7. Schaefer U. F.

    Set-up of a Method Using LC-UV to Assay Mometasone Furoate in Pharmaceutical Dosage Forms. Quím. Nova 2012, 35 (4), 818–821.

    OpenUrlGoogle Scholar
20. 20.↵
    1. Shaikh S.,
    2. Muneera M. S.,
    3. Thusleem O. A.,
    4. Tahir M.,
    5. Kondaguli A. V.

    A Simple RP-HPLC Method for the Simultaneous Quantitation of Chlorocresol, Mometasone Furoate and Fusidic Acid in Creams. J. Chromatogr. Sci. 2009, 47 (2), 178–183.

    OpenUrlCrossRefPubMedGoogle Scholar
21. 21.↵
    1. Surti N.,
    2. Naik S.,
    3. Bagchi T.,
    4. Dwarkanath B. S.,
    5. Misra A.

    Intracellular Delivery of Nanoparticles of an Antiasthmatic Drug. AAPS PharmSciTech 2008, 9 (1), 217–223.

    OpenUrlPubMedGoogle Scholar
22. 22.↵
    1. Sahasranaman S.,
    2. Issar M.,
    3. Hochhaus G.

    Metabolism of Mometasone Furoate and Biological Activity of the Metabolites. Drug Metab. Dispos. 2006, 34 (2), 225–233.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
23. 23.↵
    1. Valotis A.,
    2. Neukam K.,
    3. Elert O.,
    4. Högger P.

    Human Receptor Kinetics, Tissue Binding Affinity, and Stability of Mometasone Furoate. J. Pharm. Sci. 2004, 93 (5), 1337–1350.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
24. 24.↵
    1. Teng X. W.,
    2. Foe K.,
    3. Brown K. F.,
    4. Cutler D. J.,
    5. Davies N. M.

    High-Performance Liquid Chromatographic Analysis of Mometasone Furoate and Its Degradation Products. J. Pharm. Biomed. Anal. 2001, 26 (2), 313–319.

    OpenUrlPubMedGoogle Scholar
25. 25.↵
    1. Forsatz B.,
    2. Snow N. H.

    HPLC with Charged Aerosol Detection for Pharmaceutical Cleaning Validation. LCGC North Am. 2008, 25, 960–968.

    OpenUrlGoogle Scholar
26. 26.↵
    Federal Government of Brazil. Agência Nacional de Vigilância Sanitária. ANVISA. RDC n. 166, 24 de Julho de 2017. Brasília: Diário Oficial da União 2017.

    Google Scholar
27. 27.↵
    International Conference for Harmonisation. Quality Guideline Q2(R1):Validation of Analytical Procedures: Text and Methodology. ICH: Geneva, 2005.

    Google Scholar
28. 28.↵
    AOAC Official Methods of Analysis. Appendix F: Guidelines for Standard Method Performance Requirements. AOAC International: Rockville, MD, 2016

    Google Scholar
29. 29.↵
    1. de Souza S. V. C.,
    2. Junqueira R. G.

    A Procedure to Assess Linearity by Ordinary Least Squares Method. Anal. Chim. Acta 2005, 552 (1–2), 25–35.

    OpenUrlGoogle Scholar
30. 30.↵
    1. Shapiro S. S.,
    2. Wilk M. B.

    An Analysis of Variance Test for Normality (Complete Samples). Biometrika 1965, 52 (3–4), 591–611.

    OpenUrlCrossRefWeb of ScienceGoogle Scholar
31. 31.↵
    1. Cochran W. G.

    The Distribution of the Largest of a Set of Estimated Variances as a Fraction of Their Total. Ann. Hum. Genet. 1941, 11 (1), 47–52.

    OpenUrlGoogle Scholar